Minimizing Complications: Sedation and Monitoring

Gastrointestinal Endoscopy Clinics of North America

Volumn 17, Issue 1, 2007, Pages 11-28

  Vargo, John J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; BENZOCAINE; BENZODIAZEPINE; DROPERIDOL; FENTANYL; MIDAZOLAM; NARCOTIC AGENT; OPIATE; OXYGEN; PETHIDINE; PLACEBO; PROPOFOL;

ANAPHYLAXIS; ANESTHESIA; APNEA; ASPIRATION; ASSISTED VENTILATION; BISPECTRAL INDEX; CAPNOGRAPHY; CLINICAL PRACTICE; CLINICAL TRIAL; GASTROINTESTINAL ENDOSCOPY; HEMATOLOGIC DISEASE; HUMAN; HYPOXEMIA; INDUCED HYPOTENSION; LARYNX SPASM; METHOHEMOGLOBINEMIA; OXYGEN SATURATION; PATIENT SATISFACTION; PRIORITY JOURNAL; PULSE OXIMETRY; QT PROLONGATION; RESPIRATORY TRACT DISEASE; REVIEW; SEDATION; SIDE EFFECT; TRANSCUTANEOUS CARBON DIOXIDE MONITORING;

CONSCIOUS SEDATION; DIGESTIVE SYSTEM DISEASES; ENDOSCOPY, GASTROINTESTINAL; HUMANS; MONITORING, INTRAOPERATIVE; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 33947713985     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2006.10.004     Document Type: Review

References (64)

1. Pierce E.C. The 34th Rovnestine Lecture. 40 years behind the mask: safety revisited. Anesthesiology 84 (1996) 965-975
2. Warden J.C., and Holland R. Anesthesia mortality. Anaesth Intensive Care 23 (1995) 255-256
3. Dripps R.D., Lamont A., and Echenhoff J.E. The role of anesthesia in surgical mortality. JAMA 187 (1961) 261-266
4. Institute of Medicine. Setting performance standards and expectations. In: Kohn L., Corrigan J., and Donaldson M. (Eds). To err is human: building a safer health system (2000), National Academy Press, Washington DC 144-155
5. Waring J.P., Baron T.H., Hirota W.K., et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc 58 (2003) 317-322
6. Gross J.B., Bailey P.L., Caplan R.A., et al. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 96 (2002) 1004-1017
7. Joint Commission Resources, Organizations. New definitions, revised standards address the continuum of sedation and anesthesia. Jt Comm Perspect 20 (2000) 10-15
8. Cote C.J., Notterman D.A., Karl H.W., et al. Adverse events and risk factors in pediatrics: a critical incident analysis of contributing factors. Pediatrics 105 (2000) 805-814
9. Malviya S., Voepel-Lewis T., and Tait A.R. Adverse events and risk factors associated with sedation of children by non-anesthesiologists. Anesth Analg 85 (1997) 1207-1213
10. Silvis S.E., Nebel O., Rogers G., et al. Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy survey. JAMA 235 (1976) 928-930
11. Arrowsmith J.B., Gertsman B.B., Fleischer D.E., et al. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc 37 (1991) 421-427
12. Sharma V.K., Nguyen C.C., De Garmo P., et al. Cardiopulmonary complications (CPC) after gastrointestinal endoscopy (GIE): the Clinical Outcomes Research Initiative (CORI) experience. Gastrointest Endosc 55 (2002) AB99
13. Quine M.A., Bell G.D., McCloy R.F., et al. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut 36 (1995) 462-467
14. Gangi S., Saidia F., Patel K., et al. Cardiovascular complications after GI endoscopy: occurrence and risks in a large hospital system. Gastrointest Endosc 60 (2004) 679-685
15. Fisher L., Fisher A., and Thomson A. Cardiopulmonary complications of ERCP in older patients. Gastrointest Endosc 63 (2006) 948-955
16. Riphaus A., Stergiou N., and Wehrmann T. Sedation with propofol for routine ERCP in high-risk octagenarians: a randomized controlled study. Am J Gastroenterol 100 (2005) 1957-1963
17. Patel S., Vargo J.J., Khandwala F., et al. Deep sedation occurs frequently during elective endoscopy with meperidine and midazolam. Am J Gastroenerol 100 (2005) 2689-2695
18. Froehlich F., Harris J.K., Wietslisbach V., et al. Current sedation and monitoring practice: an international observational study (EPAGE). Endoscopy 38 (2006) 461-469
19. Cohen L.B., Weclser J.S., Gaetano J.N., et al. Endoscopic sedation in the United States: results from a nationwide study. Am J Gastroenterol 101 (2006) 967-974
20. Bell G.D., Bown S., and Morden A. Prevention of hypoxemia during upper gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet (1987) 1022-1024
21. Griffin S.M., Chung S.C.S., Leung J.W.C., et al. Effect of intranasal oxygen on hypoxia and tachycardia during endoscopic cholangiopancreatography. Br Med J 300 (1990) 83-84
22. Pedersen T., Moller A.M., and Pedersen B.D. Pulse oximetry for perioperative monitoring: systematic review of randomized, controlled trials. Anesth Analg 96 (2003) 426-431
23. Davidson J.A.H., and Hosie H.E. Limitations of pulse oximetry: respiratory insufficiency-a failure of detection. BMJ 307 (1993) 372-373
24. Hutton P., and Clutton-Brock T. The benefits and pitfalls of pulse oximetry. BMJ 307 (1993) 457-458
25. Jurell K.R., O'Connor K.W., Slack J., et al. Effect of supplemental oxygen on cardiopulmonary changes during gastrointestinal endoscopy. Gastrointest Endosc 40 (1994) 665-670
26. Nelson D.B., Freeman M.L., Silvis S.E., et al. A randomized, controlled trial of transcutaneous carbon dioxide monitoring during ERCP. Gastrointest Endosc 51 (2000) 288-295
27. Vargo J.J., Zuccaro G., Dumot J.A., et al. Automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy. Gastrointest Endosc 55 (2002) 826-831
28. Vargo J.J., Zuccaro G., Dumot J., et al. Gastroenterologist-administered propofol versus meperidine and midazolam for ERCP and EUS: a randomized, controlled trial with cost effectiveness analysis. Gastroenterology 123 (2002) 8-16
29. Zafar S., Ayappa I., Norman R., et al. Choice of oximeter affects apnea-hypopnea index. Chest 127 (2005) 80-88
30. Koga I., Hamada Y., Terada T., et al. Degree of variation in cerebral tissue concentration index (TOI) and normalized tissue hemoglobin index (NTHI) measured by near-infrared spectroscopy (NIRO-100). Anesthesiology 103 (2005) A22
31. Liu B., Yu H., Yin Y., et al. Prediction of depth of sedation and anesthesia by a new entropy-based ENI monitor™: a preliminary study. Anesthesiology 103 (2005) A800
32. Shah N., Chitkara A., Miller J., et al. Motion induced failure rates of pulse oximeters (POs)-failure rates and recovery times in human volunteers. [abstract]. Anesthesiology 103 (2005) A881
33. Soto R.G., Fu E.S., Vila H., et al. Capnography accurately detects apnea during monitored anesthesia care. Anesth Analg 99 (2004) 379-382
34. Zuccaro G., Radaelli F., Vargo J., et al. Routine use of supplemental oxygen prevents recognition of prolonged apnea during endoscopy. Gastrointest Endosc 51 (2000) AB141
35. Lightdale J.R., Goldman D.A., Feldman H.A., et al. Microstream capnography improves patient monitoring during moderate sedation: a randomized, controlled trial. Pediatrics 117 (2006) 1170-1178
36. Bower A.L., Ripepi A., Dilger J., et al. Bispectral index monitoring of sedation during endoscopy. Gastrointest Endosc 52 (2000) 192-196
37. Bell J.K., Laasch H.U., Wibraham L., et al. Bispectral index monitoring for conscious sedation: better, safer, faster. Clin Radiol 59 (2004) 1106-1113
38. Chen S.C., and Rex D.K. An initial investigation of bispectral index monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy. Am J Gastroenterol 99 (2004) 1081-1086
39. Clarke A.C., Chiragakis L., Hillman L.C., et al. Sedation for endoscopy: the safe use of propofol by general practitioner sedationists. Med J Aust 176 (2002) 158-161
40. Tohda G., Higashi S., Wakahara S., et al. Propofol sedation during endoscopic procedures: safe and effective administration by registered nurses supervised by endoscopists. Endoscopy 38 (2006) 360-367
41. Heuss L.T., Schieper P., Drewe J., et al. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc 57 (2003) 664-671
42. Rex D.K., Sipe B.W., Kinser K.M., et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2,000 endoscopic cases. Am J Gastroenterol 97 (2002) 1159-1163
43. Koshy G., Nair S., Norkus E.P., et al. Propofol versus midazolam and meperidine for conscious sedation in GI endoscopy. Am J Gastroenterol 95 (2000) 1476-1479
44. Rex D.K., Heuss L.T., Walker J.A., et al. Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy. Gastroenterology 129 (2005) 1384-1391
45. Yusoff I.F., Raymond G., and Sahai A.V. Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients. Gastrointest Endosc 60 (2004) 356-360
46. Walker J.A., McIntyre R.D., Scleinitz P.F., et al. Nurse-administered propofol sedation without anesthesia specialists in 9152 endoscopic cases in an ambulatory surgery center. Am J Gastroneterol 98 (2003) 1744-1750
47. Wehrmann T., Kokapick S., Lembcke B., et al. Efficacy and safety of intravenous propofol sedation for routine ERCP: a prospective, controlled study. Gastrointest Endsoc 49 (1999) 677-683
48. Ulmer B.J., Hansen J.J., Overly C.A., et al. Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists. Clin Gastroenterol Hepatol 1 (2003) 425-432
49. Sipe B.W., Rex D.K., Latinovich D., et al. Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc 55 (2002) 815-825
50. Wehrmann T., Grotkamp J., Stergiou N., et al. Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial. Gastrointest Endosc 56 (2002) 817-824
51. Weston B.R., Chadalawada V., Chalasani N., et al. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol 98 (2003) 2440-2447
52. Fanti L., Agostoni M., Casati A., et al. Target-controlled propofol infusion during monitored anesthesia in patients undergoing ERCP. Gastrointest Endosc 60 (2004) 361-366
53. Cohen L.B., Dubovsky A.N., Aisenberg J., et al. Propofol for endoscopic sedation: a protocol for safe and effective administration by the gastronenterologist. Gastrointest Endosc 58 (2003) 725-732
54. Cohen L.B., Hightower C.D., Wood D.A., et al. Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc 59 (2004) 795-802
55. Qadeer M.A., Vargo J.J., Khandwala F., et al. Propofol versus traditional agents for gastrointestinal endoscopy: a meta-analysis. Clin Gastroenterol Hepatol 3 (2005) 1049-1056
56. Fechner J., Ihmsen H., Schiessel C., et al. Sedation with GPI 15715, a water soluble prodrug of propofol, using a target-controlled infusion in volunteers. Anesth Analg 100 (2005) 701-706
57. Fuhrmans V. Making colonoscopies more comfortable. Wall Street Journal (December 27, 2005) D1
58. Wilcox C.M., Forsmark C.E., and Cello J.P. Utility of droperidol for conscious sedation in gastrointestinal endoscopic procedures. Gastrointest Endosc 98 (1990) 289-290
59. Cohen J.B., Haber G.B., Dorai J.A., et al. A randomized double blind study of the use of droperidol for conscious sedation during therapeutic endoscopy in difficult to sedate patients. Gastrointest Endosc 51 (2000) 546-551
60. FDA strengthens warnings for droperidol. Available at: www.fda.gov/bbs/topics/ANSWERS/2001/ANS01123.html. Accesed January 29, 2007.
61. Yimchareon P., Fogel E., Kovacs R., et al. Droperidol, when used for sedation during ERCP, may prolong the QT interval. Gastrointest Endosc 63 (2006) 979-985
62. Moore T.J., Walsh C.S., and Cohen M.R. Reported adverse event cases of methemoglobinemia associated with benzocaine products. Arch Intern Med 164 (2004) 1192-1196
63. Patel D., Chopra S., and Berman M.D. Serious systemic toxicity resulting from use of tetracaine for pharyngeal anesthesia in upper endoscopic procedures. Dig Dis Sci 34 (1989) 882-884
64. Evans L.T., Saberi S., Kim H.M., et al. Pharyngeal anesthesia during sedated EGDs: is the "spray" beneficial? A meta-analysis and systematic review. Gastrointest Endosc 63 (2006) 761-766